Arena Pharmaceuticals (ARNA) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Arena Pharmaceuticals (ARNA)

ARNA 99.99

0.0%

Mar 15 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: targetedmoab who wrote (1637)	3/16/2010 2:17:13 PM
From: scaram(o)uche	2 Recommendations Read Replies (1) of 2274

>> obviously you know nothing about clinical trials << Would you share with us, small molecule, the average duration of a single ascending dose portion of a phase I? If you can't come up with an average, how about just a pointer to a couple of SADs that did take 14 months or longer. Thanks, in advance. How long can we expect the MAD to take? TIA. Including the phase Ib portion, what could be the expected total length of the phase I program? We know that you're very comfortable with 14 months for the SAD portion. TIA. Thanks! Rick

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next